Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial - Wikidata - thesis-toulmin - TriplyDB

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

http://www.wikidata.org/entity/Q28250518

about

Non-steroid agents for idiopathic pulmonary fibrosis Combined pulmonary fibrosis and emphysema syndrome: a review Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy Cytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBD Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis Pharmacological management of IPF New perspectives on management of idiopathic pulmonary fibrosis Clinical trials of investigational agents for IPF: a review of a Cochrane report Acute and subacute idiopathic interstitial pneumonias The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review Pulmonary vaccination as a novel treatment for lung fibrosis Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges Update on diagnosis and treatment of idiopathic pulmonary fibrosis Update on therapeutic management of idiopathic pulmonary fibrosis Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis Clinical implications of interferon-γ genetic and epigenetic variants Natural killer cells in infection and inflammation of the lung Adverse events of pirfenidone for the treatment of pulmonary fibrosis: a meta-analysis of randomized controlled trials Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis Mechanisms of fibrosis: therapeutic translation for fibrotic disease Study design implications of death and hospitalization as end points in idiopathic pulmonary fibrosis Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia.Predicting pulmonary fibrosis disease course from past trends in pulmonary function.Fibrocytes and the pathogenesis of diffuse parenchymal lung disease.High-resolution CT of complications of idiopathic fibrotic lung disease The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance.YKL-40 in pediatric asthma, MUC5B promoter polymorphism in idiopathic pulmonary fibrosis, and esmolol in septic shock.Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials.Update in diffuse parenchymal lung disease 2011 Anti-asialo GM1 NK cell depleting antibody does not alter the development of bleomycin induced pulmonary fibrosis.Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis.Advances in the management of idiopathic pulmonary fibrosis.An alternative to lung inflammation and fibrosis.Lung microbiome and host immune tone in subjects with idiopathic pulmonary fibrosis treated with inhaled interferon-γ.Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.Bone morphogenetic protein-inducer tilorone identified by high-throughput screening is antifibrotic in vivo.Pirfenidone treatment of idiopathic pulmonary fibrosis.

P2860

Q24235478-1A91A2A6-3562-4ECC-A086-73AA90EEB840 Q24614740-F464DC49-818D-41BC-9395-AB1B9D4CD333 Q26738458-2552E888-5FA6-457C-8116-148494DD13AB Q26740540-022D0FF4-F618-4D02-99A5-0B7F53B1B136 Q26747694-227BCDF5-8610-427F-BBBF-EFC0C3B78AC6 Q26748808-283813B6-B283-4944-841C-06BE3956AA2A Q26765586-DB043525-1FAA-4DF4-9515-3FBC31F9A050 Q26823161-00B3DFA2-200B-400D-BE30-A211A6356B50 Q26824327-8DD9C9B8-DE2E-442E-BAE4-2A326393BE68 Q26992007-1954DB8F-9903-45B5-81B5-1976A6621330 Q27309062-C6C9A911-5BEC-4DE1-BE0E-C141540C33E3 Q27499290-C76BF5BD-4375-4A07-B618-4F2D3AF081F3 Q28083702-DCEBCCFA-AA95-4EA9-A900-EB0E447153EE Q28083944-C758B2FE-DF9D-4EFA-B2D0-D23808106846 Q28291143-981A2C98-1D11-4C81-A377-4F6EF827817D Q28308246-A06671AD-4CF4-4237-A8EF-C455BF859E8F Q28308276-699A5E61-DA7C-4514-A782-E8072D1D5901 Q28383437-F920A0D9-1FF0-4601-B5F8-5FD0496F7DF1 Q28391714-D0C85718-086E-4957-89DE-FFEDA8D3A9A5 Q28484304-1331CECA-A819-439B-8779-2338EF2A1D8C Q28943334-F406C91B-E47C-4A7F-BE0D-5A57C7758900 Q29620307-A5F1DDF7-B7D7-49C8-BA8C-A83DC8CC237F Q30370058-40D59542-8A08-4A66-AB32-FD5FDBAF52EE Q30388977-4EE5E23C-4B0F-4C43-8420-562287CECF6E Q30407660-C3A22726-9191-4788-8E7A-74AD307D89E9 Q30426516-A9639A7B-92CB-4EF3-9E8B-0C39C442A627 Q30462254-B2360FAF-DC03-4267-AA65-0ACDC9830EF9 Q33586556-702F9BBE-CEA7-42C8-BB2D-3172419BC73A Q33732174-3073807C-3391-4980-A584-2CAB13FEA261 Q33738724-AE9BD0A6-7841-4623-B888-2612946DC632 Q33738931-5B3ABE10-DD69-43A7-B84B-BE8BFC664A45 Q33748545-427365FB-23C1-4258-A0F4-3B61EA175A84 Q33769962-1E63DC3A-13E8-44A0-8AB6-79ED24BC0853 Q33814226-93319100-CE43-418B-9F66-CC29860141BA Q33882346-9E1EF2B1-0FD2-41F3-A3CC-CCF784EFAE0F Q33897430-FAE7303E-20B5-4F98-A577-007D906CFA32 Q33908569-28AC26AF-1B1D-4AA8-8FA2-1DE59E1A0DEB Q34432217-1DCB4E78-1992-41A9-90DD-DB398DECAB07 Q34519796-1A682F7C-AC69-42E4-BA14-5F1269494BA6 Q34574174-97DD1AA4-3097-4589-BE48-1947F320CCC6

P2860

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

http://www.wikidata.org/entity/Q28250518

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Effect of interferon gamma-1b ...... ised, placebo-controlled trial

@ast

Effect of interferon gamma-1b ...... ised, placebo-controlled trial

@en

Effect of interferon gamma-1b ...... ised, placebo-controlled trial

@nl

type

label

Effect of interferon gamma-1b ...... ised, placebo-controlled trial

@ast

Effect of interferon gamma-1b ...... ised, placebo-controlled trial

@en

Effect of interferon gamma-1b ...... ised, placebo-controlled trial

@nl

prefLabel

Effect of interferon gamma-1b ...... ised, placebo-controlled trial

@ast

Effect of interferon gamma-1b ...... ised, placebo-controlled trial

@en

Effect of interferon gamma-1b ...... ised, placebo-controlled trial

@nl

P1433

Q28250518-64E8DAD8-0028-470E-8553-DD060459B91A

P1476

Q28250518-01DCF137-C802-41B4-996E-FCF95BF94F41

P2093

Q28250518-08AC63A8-B704-4E75-8DA2-19C85487C22D

Q28250518-0C06A6DE-5660-4D18-A22F-87191B5C9409

Q28250518-293CD399-DF1D-4A53-9C1B-B690886499F9

Q28250518-64FB7960-517C-465F-B1F4-1E5EB5610312

Q28250518-756B8D2A-7D1D-417B-B450-F0C99D3BB35D

Q28250518-80FA16E0-3763-4938-A232-94C6E9AC4509

Q28250518-83CF89E1-25C1-42D4-8BA6-9008EE5621F2

Q28250518-C888FB47-5F7A-4DA0-B201-3683B4896E9B

Q28250518-CF14DF8F-4052-4A92-8D92-592BC7E40B34

Q28250518-CF87EBDC-F374-44E0-AD0B-D77723A10989

P304

Q28250518-5D47340D-4108-4F3F-8EBB-BBD541656CB0

P31

Q28250518-2EDF4CC1-CF34-4169-BD3A-FDF6959FB8C0

P3181

Q28250518-4ED335E2-E2B3-4B72-93BC-48835629C0CD

P356

Q28250518-439EA510-DFDE-44B4-BDE5-3287098D804C

P407

Q28250518-7D1533DC-5DBC-4634-A377-9406EE81025F

P433

Q28250518-BED9A64A-9CF9-4E6A-B1BB-F53C48F62E94

P478

Q28250518-52A2AF3E-8616-4046-861D-C89D878907D3

P50

Q28250518-1524C698-62E7-4675-8987-6B00D1D7D286

Q28250518-5167790E-E37E-4691-87A5-F1A01B35900B

P577

Q28250518-2C7DBFC3-CFDF-40E1-AFE9-15B9D426AB68

P698

Q28250518-2B56A24D-5A7C-459D-BDAF-441A2690B9AC

P921

Q28250518-94EE7367-E219-4353-8258-2D6265A8BCD9

Q28250518-A2B3449D-6E0D-4F6B-8E66-1B10887FFAAB

Q28250518-B11A2B2B-96F7-44FB-8AA9-BF5EF846B5C2

Q28250518-DD791607-E7B7-4B9C-8479-C17DAF16CF94

P3181

P356

S0140-6736(09)60551-1

P1433

P1476

Effect of interferon gamma-1b ...... ised, placebo-controlled trial

@en

P2093

Carlo Albera

http://www.w3.org/2001/XMLSchema#string

Dominique Valeyre

http://www.w3.org/2001/XMLSchema#string

Javier Szwarcberg

http://www.w3.org/2001/XMLSchema#string

Lisa Lancaster

http://www.w3.org/2001/XMLSchema#string

Paul W Noble

http://www.w3.org/2001/XMLSchema#string

Phil Hormel

http://www.w3.org/2001/XMLSchema#string

Roland M du Bois

http://www.w3.org/2001/XMLSchema#string

Steven A Sahn

http://www.w3.org/2001/XMLSchema#string

Talmadge E King

http://www.w3.org/2001/XMLSchema#string

Williamson Z Bradford

http://www.w3.org/2001/XMLSchema#string

P304

222-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

332880

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/S0140-6736(09)60551-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

9685

http://www.w3.org/2001/XMLSchema#string

P478

374

http://www.w3.org/2001/XMLSchema#string

P50

Michiel Thomeer

Ulrich Costabel

P577

2009-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19570573

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

multicenter trial